Abiopharma

🔍 North Janine (Director)

Company: MERCER INTERNATIONAL INC. (MERC)

Report Date: 2026-06-02

Detailed Transactions and Holdings:

• Acquired 25,000 shares of Cash Settled Deferred Stock Units (Derivative)
  Date: 2026-06-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 80,289.30 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F1, F1, F1, F1, F1

Footnotes:

• F1: Represents cash settled deferred stock units ("DSUs") issued by Mercer International Inc. ("Mercer"), as a grant to the Reporting Person, at the election of the Reporting Person as an equity grant under Mercer's non-employee director compensation program in respect of the board term commencing June 1, 2026 and ending at its next regularly scheduled annual general meeting in 2027 (the "2027 AGM"). Each DSU represents the right to receive a cash payment equal to the fair market value of one share of Mercer's common stock on the redemption date(s) and dividend equivalents after the Reporting Person ceases to be a director of Mercer, unless deferred in accordance with its terms. These DSUs vest on the earlier of the one-year anniversary of the grant date or the date of the 2027 AGM.